Specific norepinephrine and serotonin uptake inhibitors in man: A crossover study with pharmacokinetic, biochemical, neuroendocrine and behavioral parameters

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Acta Psychiatrica Scandinavica Supplementum

• Publication date

  1981-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/j.1600-0447.1981.tb00716.xPMID 6452790
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Single-dose kinetics predict steady-state concentrations on imipramine and desipramine.

  1980cited by this paper
• Pharmacokinetics of zimelidine

  1980cited by this paper
• Preliminary clinical test of zimelidine (H 102/09), a new 5‐HT uptake inhibitor

  1979cited by this paper
• Acute effects of zimelidine and alaproclate, two inhibitors of serotonin uptake, on neuroendocrine function.

  1979cited by this paper
• Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depression

  1979influential reference
• Zimelidine: A therapeutic and pharmacokinetic study in depression

  1979cited by this paper
• Rapid mood cycles after a noradrenergic but not a serotonergic antidepressant.

  1979cited by this paper
• Phase advance of the circadian sleep-wake cycle as an antidepressant.

  1979cited by this paper
• Comparative pharmacokinetics of zimelidine and desipramine in man following acute and chronic administration.

  1979cited by this paper
• Straight-Phase Ion-Pair Chromatography of Zimelidine and Similar Divalent Amines Part I Bioanalysis

  1979cited by this paper
• Imipramine and desipramine in plasma and spinal fluid: relationship to clinical response and serotonin metabolism.

  1978cited by this paper
• Zimelidine: A new antidepressant?

  1978cited by this paper
• Research diagnostic criteria: rationale and reliability.

  1978cited by this paper
• Development of beta-adrenergic receptor subsensitivity by antidepressants.

  1977influential reference
• Development of β-adrenergic receptor subsensitivity by antidepressants

  1977cited by this paper
• Stimulation of growth hormone secretion by desimipramin and chlorimipramin in man.

  1977cited by this paper
• Clinical implications of imipramine plasma levels for depressive illness.

  1977cited by this paper
• Initial clinical trial based on biochemical methodology of zimelidine (a serotonin uptake inhibitor) in depressed patients

  1977cited by this paper
• Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine

  1977cited by this paper
• Simultaneous measurement of imipramine and desipramine by selected ion recording with deuterated internal standards.

  1976cited by this paper
• Psychomotor activity as a correlate of Depression and sleep in acutely disturbed psychiatric inpatients.

  1975cited by this paper
• Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain

  1975cited by this paper
• Psychomotor activity as a correlate of Depression and sleep in acutely disturbed psychiatric inpatients.

  1975cited by this paper
• Effects of amitriptyline and imipramine on amine metabolites in the cerebrospinal fluid of depressed patients.

  1974cited by this paper
• Psychomotor activity in affective states.

  1974cited by this paper
• Letter: Sterilisation of cardiac bioptome.

  1974cited by this paper
• Differential effect of chlorimipramine and nortriptyline on cerebrospinal fluid metabolites of serotonin and noradrenaline in depression

  1974cited by this paper
• 3 -Methoxy- 4 -hydroxyphenylethylene glycol in human cerebrospinal fluid.

  1971cited by this paper
• An improved procedure of 3-methoxy-4-hydroxyphenyl-ethylene glycol determination by gas-liquid chromatography.

  1970cited by this paper
• Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine.

  1969cited by this paper
• Inhibition of Uptake of Tritiated-noradrenaline in the Intact Rat Brain by Imipramine and Structurally Related Compounds

  1964cited by this paper
• Methods for Reliable Longitudinal Observation of Behavior: Development of a Method for Systematic Observation of Emotional Behavior on Psychiatric Wards

  1963cited by this paper
• Methods for reliable longitudinal observation of behavior.

  1963cited by this paper

• Response to serotonergic and noradrenergic antidepressants: a crossover study of fluoxetine and desipramine in patients with first major depression episode

  2019cites this paper
• [Response to serotonergic and noradrenergic antidepressants: a crossover study of fluoxetine and desipramine in patients with first major depression episode].

  2017cites this paper
• Persistent injury-associated anemia and aging: Novel insights

  2017cites this paper
• Zimelidine: A Review of its Pharmacological Properties and Therapeutic Efficacy in Depressive Illness

  2012cites this paper
• Sleep-Wake Cycle and Subjective Sleep Quality in Elderly Patients With Major Depression: an Actigraphy Study

  2011cites this paper
• Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression

  2004cites this paper
• Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: Interactions with Yohimbine

  2004cites this paper
• Comparison of effects of desipramine and amitriptyline on EEG sleep of depressed patients

  2004cites this paper
• Assessment of the anticholinergic effects of antidepressants in a single-dose cross-over study of salivation and plasma levels

  2004cites this paper
• Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype?

  2002cites this paper
• The role of noradrenaline and selective noradrenaline reuptake inhibition in depression.

  2002cites this paper
• Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity.

  2001cites this paper
• Catecholamines in depression: a cumulative study of urinary norepinephrine and its major metabolites in unipolar and bipolar depressed patients versus healthy volunteers at the NIMH.

  1999cites this paper
• Circadian rhythms and the pharmacology of affective illness.

  1996cites this paper
• Changes in the regulation of 5-hydroxytryptamine release by alpha2-adrenoceptors in the rat hippocampus after long-term desipramine treatment.

  1995cites this paper
• Tricyclics and newer antidepressant medications: Treatment options for treatment‐resistant depressions

  1994cites this paper
• Neurobiologic Bases of Noncognitive Behavioral Problems in Alzheimer Disease

  1994cites this paper
• Effect of fluvoxamine, imipramine and placebo on catecholamine function in depressed outpatients.

  1993cites this paper
• Zum gegenwärtigen Stand der biologischen Depressionsforschung

  1991cites this paper
• Einsatz von Antidepressiva und MAO-Hemmern in sequentieller Folge oder in Kombination miteinander als effiziente Strategie bei therapieresistenten Depressionen

  1990cites this paper
• Psychopharmacoendocrinology and Depression Research

  1990cites this paper
• Endocrine Response to Tricyclic Antidepressants and Peptides in Depression with Special Regard to Growth Hormone Secretion

  1990cites this paper
• Biogenic amines and their metabolites in body fluids of normal, psychiatric and neurological subjects.

  1989cites this paper
• Amphetamine, but Not Methylphenidate, Predicts Antidepressant Efficacy

  1988cites this paper
• Treatment strategy in depression

  1988cites this paper
• Pharmacological effects of serotonin reuptake inhibitors.

  1988cites this paper
• Biological predictors of success of antidepressant drug therapy.

  1987cites this paper
• Serotonin Reuptake Inhibition vs. Norepinephrine Reuptake Inhibition: A Double-Blind Differential-Therapeutic Study with Fluvoxamine and Oxaprotiline in Endogenous and Neurotic Depressives* **

  1987cites this paper
• Serotonin function in panic disorders. The effect of intravenous tryptophan in healthy subjects and patients with panic disorder before and during alprazolam treatment.

  1986cites this paper
• Interacting neurotransmitter systems. A non-experimental approach to the 5HIAA-HVA correlation in human CSF.

  1986cites this paper
• Saliva secretion rate and saliva composition as a model to determine the effect of antidepressant drugs on cholinergic and noradrenergic transmission.

  1986cites this paper
• The effects of desipramine, zimelidine, electroconvulsive treatment and lithium on rat brain biogenic amines: a comparison with peripheral changes.

  1986cites this paper
• Alaproclate a novel antidepressant?

  1985cites this paper
• Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment.

  1985cites this paper
• Use of specific serotonin uptake inhibitors as antidepressants.

  1985cites this paper
• Obsessive-compulsive disorder and serotonin: is there a connection?

  1985cites this paper
• Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.

  1985cites this paper
• Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment.

  1985cites this paper
• Norepinephrine in the Affective Disorders: Classic Biochemical Approaches

  1985cites this paper
• Evaluation of zimeldine in Alzheimer's disease. Cognitive and biochemical measures.

  1985cites this paper
• Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?

  1985cites this paper
• Common mechanism of action of biochemically "specific" antidepressants.

  1984cites this paper
• Psychotherapeutic drugs and biogenic amines. Current concepts and therapeutic implications.

  1984cites this paper
• Reduction of norepinephrine turnover by serotonergic drug in man.

  1984cites this paper
• Psychotherapeutic Drugs and Biogenic Amines

  1984cites this paper
• CNS Amine Metabolites

  1984cites this paper
• The effect of desmethylimipramine on the metabolism of norepinephrine.

  1984cites this paper
• Hormonal Responses to Zimelidine and Depressed Patients Desipramine in

  1984cites this paper
• Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.

  1984cites this paper
• Hormonal responses to zimelidine and desipramine in depressed patients.

  1984cites this paper
• Clinical Pharmacokinetics of Antidepressants

  1984cites this paper
• Effects of antidepressant treatments on ‘whole body’ norepinephrine turnover

  1983cites this paper
• Electroconvulsive treatment and lithium carbonate. Their effects on norepinephrine metabolism in patients with primary, major depressions.

  1983cites this paper
• A multicentre double‐blind comparative trial of zimeldine and imipramine in primary major depressive disorders

  1983cites this paper
• Alteration of norepinephrine metabolism with desipramine and zimelidine in depressed patients.

  1982cites this paper
• A double–blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression

  1982cites this paper
• Pre‐ and postsynaptic effects of zimelidine and norzimelidine on the serotoninergic system: single cell studies in the rat

  1981cites this paper